AJANTPHARM.BOAJANTPHARM.BOBSE

Revenue (LTM)

$46.5B

+10.4% YoY

Net Income (LTM)

$9.2B

+12.8% YoY

Free Cash Flow

$8.4B

Revenue CAGR (5Y)

+12.7%

—Marginsstable

FCF$8.4B

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	28,470	32,841↑15.4%	37,426↑14.0%	42,087↑12.5%	46,481↑10.4%
Gross Profit	21,646	23,974↑10.8%	26,324↑9.8%	30,934↑17.5%	35,773↑15.6%
Operating Income	8,637	7,816↓9.5%	7,111↓9.0%	19,677↑176.7%	22,637↑15.0%
Net Income	6,539	7,127↑9.0%	5,880↓17.5%	8,162↑38.8%	9,204↑12.8%
EBITDA	10,241	10,445↑2.0%	8,814↓15.6%	12,565↑42.6%	12,683↑0.9%
EPS Diluted	50.06	54.96↑9.8%	45.89↓16.5%	64.77↑41.1%	73.53↑13.5%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	1,775	2,064↑16.3%	3,298↑59.8%	1,295↓60.7%	1,762↑36.1%
Total Current Assets	20,276	22,645↑11.7%	28,340↑25.2%	27,309↓3.6%	28,430↑4.1%
Total Assets	37,787	40,556↑7.3%	46,790↑15.4%	46,384↓0.9%	50,150↑8.1%
Total Current Liabilities	6,486	6,474↓0.2%	11,393↑76.0%	8,958↓21.4%	9,961↑11.2%
Total Liabilities	7,831	7,912↑1.0%	12,910↑63.2%	10,710↓17.0%	12,247↑14.3%
Total Equity	29,956	32,643↑9.0%	33,880↑3.8%	35,674↑5.3%	37,903↑6.2%
Total Debt	314	250↓20.2%	356↑42.3%	353↓1.0%	474↑34.4%
Net Debt	-1,462	-1,813↓24.1%	-2,942↓62.2%	-942↑68.0%	-1,288↓36.7%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	5,763	5,620↓2.5%	7,918↑40.9%	7,851↓0.8%	11,572↑47.4%
Capital Expenditure	-1,716	-1,488↑13.3%	-1,745↓17.2%	-1,524↑12.7%	-3,179↓108.6%
Free Cash Flow	4,047	4,132↑2.1%	6,173↑49.4%	6,327↑2.5%	8,393↑32.7%
Stock-Based Comp	0	3↑1400.0%	2↓26.7%	55↑2395.5%	39↓29.3%
Net Change in Cash	-247	289↑216.8%	1,253↑333.7%	-2,014↓260.8%	460↑122.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance